Company Filing History:
7 out of 13 
3 out of 274 
1 out of 52 Years Active: 1995-2008
Title: The Innovations of Robert A. Murgita
Introduction
Robert A. Murgita is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of immunology and cell biology, holding a total of 11 patents. His work focuses on the therapeutic applications of recombinant human alpha-fetoprotein.
Latest Patents
Murgita's latest patents include groundbreaking methods for utilizing recombinant human alpha-fetoprotein. One patent discloses methods of inhibiting autoreactive immune cell proliferation in mammals by administering a therapeutically effective amount of recombinant human alpha-fetoprotein or its anti-proliferative fragments. Another patent outlines a method for promoting bone marrow cell proliferation in mammals through the administration of unglycosylated recombinant human alpha-fetoprotein.
Career Highlights
Throughout his career, Murgita has worked with various organizations that have allowed him to advance his research. He has been associated with Martinex R & D Inc. and McGill University, where he has contributed to innovative research and development projects.
Collaborations
Due to space constraints, the details of his collaborations will not be included.
Conclusion
Robert A. Murgita's contributions to the field of immunology through his patents and research collaborations highlight his role as a significant innovator. His work continues to influence therapeutic strategies in medicine.